• Loading stock data…

Genprex Receives U.S. FDA Fast Track Designation for REQORSA™ Immunogene Therapy in Combination With Keytruda® for the Treatment of Non-Small Cell Lung Cancer

[#item_full_content]

Print Friendly, PDF & Email
Spread the word